The Global Plasma Protein Therapeutics Market is on a significant growth trajectory, projected to reach approximately USD 40 billion by 2030. This expansion is driven by the indispensable role that plasma protein therapies play in treating a wide array of medical conditions, such as hemophilia,
The establishment of the BioHub Maryland Training and Education Center in Montgomery County marks a pivotal moment for the biopharma industry, both locally and nationally. With a $3 million investment from Montgomery County coupled with an additional $1.25 million from the Moore-Miller
ISO 15189 accreditation provides a solid framework for quality and technical competence, thereby significantly improving laboratory patient care by establishing comprehensive standards that medical laboratories should meet. Navigate BioPharma Services, Inc.’s recent accreditation by the College of
Sterling Pharma Solutions is significantly expanding its GMP antibody-drug conjugate (ADC) manufacturing capacity with a £10 million investment aimed at doubling the current capacity at its Deeside, UK site. This expansion involves commissioning a new 2,300-square-foot suite, which includes a
MilliporeSigma has announced a substantial $76 million investment to expand its Bioconjugation Center of Excellence in St. Louis, Missouri, aiming to triple its current capacity for Antibody-Drug Conjugates (ADCs). This significant expansion will encompass upgrading 34,000 square feet of existing
Ardena, a prominent Contract Development and Manufacturing Organization (CDMO) in the pharmaceutical sector, is expanding its Bioanalytical Services in the Netherlands in a substantial way. The company's latest strategic initiatives involve establishing a state-of-the-art bioanalytical laboratory
